Healthy Eating Index 2015 Score Linked to Overactive Bladder
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
TUESDAY, Oct. 29, 2024 -- There is a positive association between a higher Healthy Eating Index (HEI)-2015 score and overactive bladder (OAB), according to a study published online Sept. 16 in Frontiers in Nutrition.
Xuanyu Hao, from the Shengjing Hospital of China Medical University in Shenyang, and colleagues examined the association between HEI-2015 and OAB using data from the National Health and Nutrition Examination Survey 2005 to 2020 datasets. The dose-response association was investigated using the restricted cubic spline model.
Data were included for 29,206 participants, including 6,184 OAB patients. The researchers observed an independent association for a higher continuous HEI-2015 value with a lower incidence of OAB (odds ratio, 0.87). Similarly, a significant association was seen for the highest versus the lowest quartile categorical HEI-2015 with lower odds of OAB (odds ratio, 0.72). A favorable nonlinear dose-response relationship was seen between HEI-2015 and OAB in the restricted cubic spline curve.
"We recommend adherence to United States dietary recommendations as a potential behavioral approach for OAB prevention," the authors write. "However, further large-scale long-term prospective cohort studies across various regions are necessary to validate the outcomes of this investigation."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-10-30 12:00
Read more
- Icotrokinra Delivered an Industry-Leading Combination of Significant Skin Clearance with Demonstrated Tolerability in a Once Daily Pill in Phase 3 Topline Results
- Unexplained Weight Loss and What It Can Mean for Your Health
- Greater Fine Particulate Matter Linked to Increased Odds of Eczema
- FDA Approves Aucatzyl (obecabtagene autoleucel) for Adults with Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia
- Burden of Diabetes, Untreated Diabetes Increased From 1990 to 2022
- AHA: Intensive Strategy for Lowering Systolic BP Beneficial in Type 2 Diabetes
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions